Funding · Company
CoRegen, Inc.
Aspen, COBiotech & Pharma
CoRegen, Inc. of Aspen, CO has disclosed $83M across 2 Form D offerings filed with the SEC between Feb 28, 2025 and May 22, 2025.
$83M
Total disclosed
2
Form D offerings
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersAspen, COIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0002012886Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →